Lesson plan
Trofinetide
Trofinetide, sold under the brand name Daybue among others, is a medication used for the treatment of Rett syndrome. It is taken by mouth. The most common adverse reactions include diarrhea and vomiting. Trofinetide was approved for medical use in the United States in March 2023. The US Food and Drug Administration considers it to be a first-in-class medication.
Article summary
Trofinetide, sold under the brand name Daybue among others, is a medication used for the treatment of Rett syndrome. It is taken by mouth. The most common adverse reactions include diarrhea and vomiting. Trofinetide was approved for medical use in the United States in March 2023. The US Food and Drug Administration considers it to be a first-in-class medication.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.